FIELD: chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to the terbinafine (Lamisil®) solid medicinal formulation possessing high effectiveness and containing the enhanced doses of terbinafine. This provides decreasing the total dose of the preparation administrated by a course treatment. Proposed medicinal formulation represents tablets with cover or mini-tablets placed into capsules or sachet.
EFFECT: improved and valuable pharmaceutical properties of drug.
25 cl, 8 tbl, 1 dwg
Authors
Dates
2007-05-10—Published
2002-07-19—Filed